How Will the Ruminant Vaccines Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the ruminant vaccines market grown in recent years?
The market size for ruminant vaccines has experienced robust growth in the past few years. The expansion is projected to rise from $2.98 billion in 2024 to approximately $3.19 billion in 2025, translating to a compound annual growth rate (CAGR) of 6.9%. Factors such as the escalating numbers of livestock, an increase in zoonotic diseases, governmental policies targeting disease elimination, a heightened demand for animal protein, and a heightened awareness of animal health have contributed to the growth witnessed in the historical phase.
How is the ruminant vaccines market size expected to evolve during the forecast period?
In the forthcoming years, the market size for ruminant vaccines is predicted to witness significant growth, reaching up to $4.13 billion by 2029 with a CAGR of 6.7%. This surge during the forecast period can be credited to increased funding in R&D, the expansion and upgrading of veterinary clinics and hospitals, rising meat and dairy consumption, emphasis on animal preventive health care, and the internationalization of livestock trading. Key trends within the forecast period will be the adaption of recombinant and DNA vaccines, advancements in autogenous vaccine applications, concentration on thermostable vaccine creation, the incorporation of AI into vaccine production, and application of nanotechnology for vaccine administration.
Get your ruminant vaccines market report here!
https://www.thebusinessresearchcompany.com/report/ruminant-vaccines-global-market-report
Which key drivers are propelling the ruminant vaccines market’s growth?
The expanding requirement for products derived from farm animals is anticipated to boost the growth of the ruminant vaccines market. Products obtained from animals include items like meat, milk, eggs, wool, leather, and other by-products like gelatin and animal fats. Several factors motivate this escalating demand, including shifting dietary habits, enhanced consumer reach, better affordability, economic growth, and varying lifestyle trends. The vaccination of ruminant livestock is crucial as it bolsters livestock farming by promoting overall animal health, preventing diseases, increasing efficiency, optimising feed usage, and ensuring a consistent and stable provision of meat, milk, and other by-products. For instance, data gathered by the Department for Environment, Food and Rural Affairs, a government entity based in the UK, revealed in February 2024 that the total livestock yield in 2022 was $25.05 billion, marking a 16% ($3.50 billion) increase from the previous year (2021). Consequently, the growing demand for products derived from livestock fuels the ruminant vaccines market.
What are the market segments in the ruminant vaccines industry?
The ruminant vaccines market covered in this report is segmented –
1) By Vaccine Type: Inactivated Vaccines, Attenuated Or Modified Live Vaccines, Other Vaccine Types
2) By Indication: Bovine Respiratory Diseases (BRD), Diarrhea Or Scours, Foot-and-Mouth Disease (FMD), Clostridial Diseases, Leptospirosis, Bovine Viral Diarrhea (BVD) Infection, Other Indication
3) By Route Of Administration: Intramuscular, Subcutaneous, Intranasal, Oral
4) By Application: Cattle, Sheep, Other Applications
5) By End-User: Veterinary Hospitals And Clinics, Livestock Farms, Research Institutes
Subsegments:
1) By Inactivated Vaccines: Killed Virus Vaccines, Bacterial Inactivated Vaccines, Subunit Vaccines
2) By Attenuated or Modified Live Vaccines: Live Attenuated Virus Vaccines, Live Bacterial Vaccines, Recombinant Live Vaccines
3) By Other Vaccine Types: DNA Vaccines, mRNA Vaccines, Viral Vector Vaccines
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20619&type=smp
Which leading companies are shaping the growth of the ruminant vaccines market?
Major companies operating in the ruminant vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Inc., Ceva Santé Animale, Virbac, Phibro Animal Health Corporation, Vetoquinol S.A., Indian Immunologicals Ltd., Anicon Labor GmbH (SAN Group), IDT Biologika GmbH, Jinyu Bio-Technology Co. Ltd., Vaxxinova International B.V., Biogenesis Bagó S.A, CZ Vaccines, Hester Biosciences Limited, Choong Ang Vaccine Laboratories Co. Ltd., Hipra Corporations, VETVACO National Veterinary Joint Stock Company, Kyoto Biken Laboratories Inc., Fatro Spa
What key trends are currently impacting the ruminant vaccines market’s development?
Leading businesses in the ruminant vaccines market are concentrating on the production of innovative solutions such as the bluetongue virus (BTV) serotype 3 vaccine. The goal is to provide effective safeguard against the bluetongue virus serotype 3, lowering mortality rates, clinical symptoms and virus spread in animals like cattle and sheep. The bluetongue virus (BTV) Serotype 3 vaccine works as a preventive inoculation protecting ruminants from the disease caused by bluetongue virus’s serotype 3. A case to point is Boehringer Ingelheim International GmbH, a biopharmaceutical organization based in Germany, which in May 2024, added Bultavo 3 to its ruminant vaccine range. This inactivated vaccine shields against bluetongue virus serotype 3, effectively curbing virus movement in the bloodstream and preventing both fatalities and clinical symptoms. The urgent need for a BTV-3 vaccine, spurred by recent outbreaks, is addressed by this new arrival, thereby reducing the strain on animal health and the resultant economic fallout for farmers.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20619
Which geographic areas are influencing the growth of the ruminant vaccines market?
North America was the largest region in the ruminant vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ruminant vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Meningococcal Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Swine Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
